homeWelcome, sign in or click here to subscribe.login
     


 

 

Business


Subscriber content preview

November 23, 2020

Pfizer seeking emergency use of its COVID-19 vaccine

By LAURAN NEERGAARD
AP Medical Writer

Pfizer said Friday it is asking U.S. regulators to allow emergency use of its COVID-19 vaccine, starting the clock on a process that could bring limited first shots as early as next month and eventually an end to the pandemic — but not until after a long, hard winter.

The action comes days after Pfizer Inc. and its German partner BioNTech announced that its vaccine appears 95% effective at preventing mild to severe COVID-19 disease in a large, ongoing study.


 
. . .


To read this story in full login or purchase a subscription.




Email or user name:
Password:
 
Forgot password? Click here.